Skip to content

Mapping the Tumor Microenvironment of Renal Clear Cell Carcinoma through Multi-omics Technologies

Mapping the Tumor Microenvironment of Renal Clear Cell Carcinoma through Multi-omics Technologies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100254
Enrollment
Unknown
Registered
2025-04-07
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal cell carcinoma

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of PLA Naval Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients clinically diagnosed with renal cancer who meet the following criteria: (1) The patient is aged between 18 and 80 years old, regardless of gender, and voluntarily signs the informed consent form for the sample library; (2) The first-line treatment is partial nephrectomy or radical nephrectomy, and the pathological examination of the surgical specimen confirms the diagnosis of renal clear cell carcinoma; (3) Patients who have at least two or more samples stored in the sample library and do not violate the regulations for sample library outflow.

Exclusion criteria

Exclusion criteria: 1.After checking the patient's medical record system, it was confirmed that patients with the following conditions are excluded: (1) having severe metabolic diseases; (2) Merge with other malignant tumors; (3) Patients who receive neoadjuvant therapy before surgery; (4) The sample quality inspection is not qualified.

Design outcomes

Primary

MeasureTime frame
Disease-free Survive;

Countries

China

Contacts

Public ContactLinhui Wang

Changhai Hospital, Naval Medical University

wanglinhui@smmu.edu.cn+86 139 0163 5510

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026